Molecules 2019, 24, 838
10 of 12
◦
3,7-Dinitro-5,10,15,20-tetrakis(3-methylphenyl)porphyrin (7b): m.p. > 300 C. 1H NMR (CDCl3, 400 MHz);
[ppm]: 8.98 (s, 2H, Hβ-pyrrole), 8.79 and 8.76 (AB-like system, J = 4.9 Hz, 4H, Hβ-pyrrole), 8.11–7.95
(m, 8H, H-Ar), 7.69–7.52 (m, 8H, H-Ar), 2.67 (s, 6H, 2 CH3), 2.65 (s, 3H, CH3), 2.61 (s, 3H, CH3), 2.28
(s, 2H, 2 NH). UV-vis (CHCl3); max [nm] (log ): 684 (3.86), 587.5 (4.02), 539 (3.97), 446 (5.21, Soret
δ
×
−
×
λ
ε
band), 396.5 (4.49). MS (ESI); m/z (% rel. int.): 764 (2), 763 (11), 762 (45), 761 (100) [isotope (M + H)+].
HR-MS (ESI): m/z calcd for C48H37N6O4 [(M + H)+]: 761.2876; found: 761.2855.
◦
2,8-Dinitro-5,10,15,20-tetrakis(3-methylphenyl)porphyrin (8b): m.p. > 300 C. 1H NMR (CDCl3, 400 MHz);
[ppm]: 9.06 (s, 2H, Hβ-pyrrole), 8.85 (d, J = 4.7 Hz, 2H, Hβ-pyrrole), 8.73 (d, J = 4.7 Hz, 2H,
Hβ-pyrrole), 8.06–7.95 (m, 8H, H-Ar), 7.68–7.55 (m, 8H, H-Ar), 2.67 (s, 6H, 2
CH3), 2.62 (s, 6H,
CH3), NH—undetected. UV-vis (CHCl3); [nm] (log ): 679 (3.83), 580.5 (4.00), 538 (4.08),
δ
×
2
×
λ
max
ε
439.5 (5.26, Soret band), 363.5 (4.44), 328 (4.37). MS (ESI); m/z (% rel. int.): 764 (2), 763 (13), 762 (48),
761 (100) [isotope (M + H)+]. HR-MS (ESI): m/z calcd for C48H37N6O4 [(M + H)+]: 761.2876; found:
761.2860.
◦
2,12-Dinitro-5,10,15,20-tetrakis(3-methylphenyl)porphyrin (9b): m.p. > 300 C. 1H NMR (CDCl3, 400 MHz);
[ppm]: 9.02 and 8.92 (AA’XX’, JAX = 5.0 Hz, 4H, Hβ-pyrrole), 9.01 (s, 2H, Hβ-pyrrole), 8.11–7.98 (m,
8H, H-Ar), 7.70–7.57 (m, 8H, H-Ar), 2.68 (s, 6H, 2 CH3), 2.63 (s, 6H, 2 CH3), 2.61 (s, 2H, 2 NH).
UV-vis (CHCl3); max [nm] (log
δ
×
×
−
×
λ
ε): 685 (3.72), 538 (3.73), 436 (4.97, Soret band), 361.5 (4.01). MS (ESI);
m/z (% rel. int.): 764 (1), 763 (8), 762 (38), 761 (100), 760 (16) [isotope M+• and (M + H)+]. HR-MS (ESI):
m/z calcd for C48H37N6O4 [(M + H)+]: 761.2876; found: 761.2862.
1
2,13-Dinitro-5,10,15,20-tetrakis(3-methylphenyl)porphyrin (10b): m.p. > 300 ◦C. H NMR (CDCl3,
400 MHz);
8.12–7.97 (m, 8H, H-Ar), 7.69–7.57 (m, 8H, H-Ar), 2.67 (s, 6H, 2
1H, NH), 2.59 (s, 1H, NH). UV-vis (CHCl3);
δ
[ppm]: 9.02 (s, 2H, Hβ-pyrrole), 8.97 (s, 2H, Hβ-pyrrole), 8.92 (s, 2H, Hβ-pyrrole),
×
CH3), 2.64 (s, 6H, 2
[nm]: 688.5, 539.5, 441 (Soret band), 370, 276.5. MS
×
CH3),
−
2.50 (s,
−
λ
max
(ESI); m/z (% rel. int.): 785 (1), 784 (4), 783 (8) [isotope (M + Na)+], 764 (2), 763 (12), 762 (46), 761 (100),
760 (9) [isotope M+• and (M + H)+]. HR-MS (ESI): m/z calcd for C48H37N6O4 [(M + H)+]: 761.2876;
found: 761.2870.
4. Conclusions
We have described herein the preparation and isolation of dinitro-isomers of TPP complexes
(and their free base derivatives), which were formed in electrophilic nitration reactions of the parent
compounds. Some of these isomers were reported in previous papers, however they were formed
in low yields [6] (or as by-products [12]), and were not characterized in details or sometimes were
characterized erroneously (e.g., the 1H NMR spectra) [6,12].
In the above reactions the formation of five dinitro-isomers is possible. Usually, we could isolate
three of them (except for [5,10,15,20-tetrakis(3-methylphenyl)porphyrinato]copper(II)). In the case of
copper complexes, the products were treated with H2SO4/CF3CO2H mixture, thus giving metal-free
porphyrins that were also fully characterized. This type of porphyrins are practically not available by
alternative methods. The synthesis of potential anticancer PDT agents derived therefrom by our group
will be reported soon.
Supplementary Materials: The following are available online. Figures S1–S56 (1H NMR, UV-vis, and MS spectra
of all the products).
Author Contributions: Conceptualization, A.M. and S.O.; Methodology, A.M.; Formal Analysis, A.M. and M.R.;
Investigation, A.M. and M.R.; Writing—original draft preparation, A.M.; Writing—review and editing, S.O. and
A.M. In summary, A.M.—70%; M.R.—20%; S.O.—10%.
Funding: This research received no external funding.
Conflicts of Interest: The authors declare no conflict of interest.